• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合素β表达作为动静脉血栓形成的一种新诊断标志物:一项单中心前瞻性研究。

Integrin β Expression as a New Diagnostic Marker for Arteriovenous Thrombosis: A Single-Center Prospective Study.

作者信息

Xi Yan, Mao Yu, Yang Fan, Xi Peng, Zhu Wei, Song Yanli, Yan Wenwen, Liao Xudong, Zhou Lin

机构信息

Department of General Practice, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.

Department of Cardiology, Tongji Hospital, Tongji University, Shanghai 200065, China.

出版信息

J Cardiovasc Dev Dis. 2023 Nov 15;10(11):461. doi: 10.3390/jcdd10110461.

DOI:10.3390/jcdd10110461
PMID:37998519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10672679/
Abstract

Integrin β plays an important role in the pathogenesis of thrombosis and inflammation, and it may be a shared pathogenic mechanism between arterial and venous thromboses. With the goal of identifying new treatment targets for thrombotic diseases and specific diagnostic markers for venous thromboembolism (VTE), this prospective clinical study was performed to clarify the relationship between integrin and thrombosis. The levels of integrin β1-3, interleukin-6 (IL-6), and C-reactive protein were significantly higher in patients with acute myocardial infarction (AMI; = 44) and acute VTE ( = 43) compared to healthy controls ( = 33). The IL-6 and integrin β1-3 levels were also significantly higher in the AMI group compared to the VTE and control groups. Logistic regression analysis identified IL-6 and integrin β1-3 levels as independent risk factors for thrombotic disease. Based on the receiver-operating characteristic curve, Youden index, sensitivity, and specificity, the diagnostic accuracy value for VTE was greater than 0.8 when integrins β1, β2, and β3 were combined. Overall, these results suggest that integrin β levels can contribute to improving the diagnosis and treatment of arteriovenous thrombosis.

摘要

整合素β在血栓形成和炎症的发病机制中起重要作用,它可能是动脉血栓和静脉血栓之间共同的致病机制。为了确定血栓性疾病的新治疗靶点和静脉血栓栓塞症(VTE)的特异性诊断标志物,开展了这项前瞻性临床研究以阐明整合素与血栓形成之间的关系。与健康对照组(n = 33)相比,急性心肌梗死(AMI;n = 44)和急性VTE(n = 43)患者的整合素β1-3、白细胞介素-6(IL-6)和C反应蛋白水平显著更高。与VTE组和对照组相比,AMI组的IL-6和整合素β1-3水平也显著更高。逻辑回归分析确定IL-6和整合素β1-3水平为血栓性疾病的独立危险因素。基于受试者工作特征曲线、约登指数、敏感性和特异性,当整合素β1、β2和β3联合使用时,VTE的诊断准确性值大于0.8。总体而言,这些结果表明整合素β水平有助于改善动静脉血栓的诊断和治疗。

相似文献

1
Integrin β Expression as a New Diagnostic Marker for Arteriovenous Thrombosis: A Single-Center Prospective Study.整合素β表达作为动静脉血栓形成的一种新诊断标志物:一项单中心前瞻性研究。
J Cardiovasc Dev Dis. 2023 Nov 15;10(11):461. doi: 10.3390/jcdd10110461.
2
Increased expressions of integrin subunit β1, β2 and β3 in patients with venous thromboembolism: new markers for venous thromboembolism.静脉血栓栓塞症患者中整合素亚基β1、β2和β3表达增加:静脉血栓栓塞症的新标志物
Int J Clin Exp Med. 2014 Sep 15;7(9):2578-84. eCollection 2014.
3
Internal relationship between symptomatic venous thromboembolism and risk factors: up-regulation of integrin β1, β2 and β3 levels.症状性静脉血栓栓塞与危险因素之间的内在关系:整合素β1、β2和β3水平上调。
Am J Transl Res. 2015 Mar 15;7(3):624-31. eCollection 2015.
4
The High Expression of Adhering and Circulating Integrin Serves as a Diagnostic Marker in Venous Thromboembolism.黏附及循环整联蛋白的高表达可作为静脉血栓栓塞症的诊断标志物。
Comput Math Methods Med. 2022 Oct 7;2022:9610071. doi: 10.1155/2022/9610071. eCollection 2022.
5
Increased expressions of integrin subunit β1, β2 and β3 in patients with cancer ------correlation analysis between risk factors of VTE and expression of core proteins.癌症患者中整合素亚基β1、β2和β3表达增加——静脉血栓栓塞危险因素与核心蛋白表达的相关性分析
Int J Clin Exp Med. 2015 Feb 15;8(2):2772-7. eCollection 2015.
6
Increased Expressions of Integrin Subunit β1, β2 and β3 in Patients with Acute Infection.急性感染患者中整合素亚基β1、β2和β3表达增加。
Int J Med Sci. 2015 Jul 25;12(8):639-43. doi: 10.7150/ijms.11857. eCollection 2015.
7
Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.下肢石膏固定后的静脉血栓形成风险:三项基于人群的病例对照研究中临床预测评分L-TRiP(石膏固定)的推导与验证
PLoS Med. 2015 Nov 10;12(11):e1001899; discussion e1001899. doi: 10.1371/journal.pmed.1001899. eCollection 2015 Nov.
8
Plasma Soluble Fibrin Is Useful for the Diagnosis of Thrombotic Diseases.血浆可溶性纤维蛋白对血栓性疾病的诊断有帮助。
J Clin Med. 2023 Mar 30;12(7):2597. doi: 10.3390/jcm12072597.
9
Predictive Value for Increased Red Blood Cell Distribution Width in Unprovoked Acute Venous Thromboembolism at the Emergency Department.急诊不明原因急性静脉血栓栓塞症中红细胞分布宽度增加的预测价值。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231193397. doi: 10.1177/10760296231193397.
10
C-reactive protein, obesity, and the risk of arterial and venous thrombosis.C 反应蛋白、肥胖与动静脉血栓形成风险。
J Thromb Haemost. 2016 Aug;14(8):1561-71. doi: 10.1111/jth.13369. Epub 2016 Jun 22.

引用本文的文献

1
A dual-center analysis of conservative versus liberal glycoprotein IIb-IIIa antagonist strategies in the treatment of ST-elevation myocardial infarction.双中心研究:比较 ST 段抬高型心肌梗死治疗中保守与激进糖蛋白 IIb-IIIa 拮抗剂策略。
Sci Rep. 2024 Jul 1;14(1):15003. doi: 10.1038/s41598-024-64652-x.

本文引用的文献

1
State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism.最新迷你综述:双重途径抑制以减少动脉和静脉血栓栓塞症。
Thromb Haemost. 2022 Aug;122(8):1279-1287. doi: 10.1055/a-1778-1083. Epub 2022 Feb 21.
2
Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases.白细胞介素-6:心脑血管疾病的新型靶点。
Front Pharmacol. 2021 Aug 24;12:745061. doi: 10.3389/fphar.2021.745061. eCollection 2021.
3
Calming the cytokine storm in COVID-19.平息新冠病毒肺炎中的细胞因子风暴
Nat Med. 2021 Oct;27(10):1674-1675. doi: 10.1038/s41591-021-01500-9.
4
COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation.COVID-19 严重程度可能受心血管疾病相关免疫失调的调节。
Viruses. 2021 May 28;13(6):1018. doi: 10.3390/v13061018.
5
Cardiovascular Outcomes With Anti-Inflammatory Therapies: Review of Literature.抗炎疗法的心血管结局:文献综述
Curr Probl Cardiol. 2022 Jun;47(6):100840. doi: 10.1016/j.cpcardiol.2021.100840. Epub 2021 Mar 19.
6
Targeting inflammation in atherosclerosis - from experimental insights to the clinic.靶向动脉粥样硬化炎症——从实验研究到临床实践。
Nat Rev Drug Discov. 2021 Aug;20(8):589-610. doi: 10.1038/s41573-021-00198-1. Epub 2021 May 11.
7
Interplay between inflammation and thrombosis in cardiovascular pathology.心血管病理学中的炎症与血栓形成的相互作用。
Nat Rev Cardiol. 2021 Sep;18(9):666-682. doi: 10.1038/s41569-021-00552-1. Epub 2021 May 6.
8
CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models.CD248 增强组织因子促凝功能,促进小鼠模型的动静脉血栓形成。
J Thromb Haemost. 2021 Aug;19(8):1932-1947. doi: 10.1111/jth.15338. Epub 2021 May 7.
9
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease.血管炎症与氧化应激:心血管疾病的主要诱因。
Oxid Med Cell Longev. 2019 Jun 23;2019:7092151. doi: 10.1155/2019/7092151. eCollection 2019.
10
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.症状性动脉粥样硬化患者双联抗血小板治疗对静脉血栓栓塞的频率、预测因素和影响。
Circulation. 2018 Feb 13;137(7):684-692. doi: 10.1161/CIRCULATIONAHA.117.031062. Epub 2017 Oct 30.